A critical breakthrough in cancer study is occurring with the use of mini-antibodies to reactivate mutated p53. This vital cancer inhibitor protein is frequently disabled in several kinds of malignancies, resulting https://listingbookmarks.com/story21974467/vhh-fragments-reactivate-the-p53-protein-a-new-hope-for-cancer-treatment